GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Targeting the Hedgehog Pathway in Pediatric Brain Tumors

$519,420
Tom Curran · St. Jude Children'S Research Hospital · P01 · FY2010 · CA

Project 1- Elucidating oncogenic KRAS in PDAC cell signaling, resistance and immunity

$519,415
Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2024 · CA

Project 2 - Preclinical studies: Overcoming tumor heterogeneity

$519,368
Steven Mark Albelda · University Of Pennsylvania · P01 · FY2018 · CA

Clinical and Laboratory Research Training for Surgical Oncologists

$519,319
Lei Zheng · Johns Hopkins University · T32 · FY2023 · CA

Copper-mediated metabolic reprogramming and ECM alterations in TNBC metastasis

$519,193
Vivek Mittal · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA

Mechanisms of Prostate Tumorigenesis Using Genetically Engineered Mouse Models

$519,127
Terry Van Dyke · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Interstitial Fluid Flow Regulates Glioma Cell Invasion

$519,122
Jennifer M Munson · Virginia Polytechnic Inst And St Univ · R37 · FY2019 · CA

Novel approach to attenuate small cell lung cancer growth and metastasis

$519,062
Mohd Wasim Nasser · University Of Nebraska Medical Center · R01 · FY2021 · CA

Novel approach to attenuate small cell lung cancer growth and metastasis

$519,062
Mohd Wasim Nasser · University Of Nebraska Medical Center · R01 · FY2020 · CA

Evaluating the potential of progestins to promote the development or progression of mammary tumors

$518,958
Christy Hagan · University Of New Mexico Health Scis Ctr · P01 · FY2025 · CA

Systemic RNA Delivery to Tumors

$518,820
Jinjun Shi · Brigham And Women'S Hospital · R01 · FY2024 · CA

Leveraging Novel Randomized Clinical Trials of Vitamin D Supplementation in Patients with Colorectal Cancer: Impact on Survival and Anti-Tumor Immunity

$518,698
Kimmie Ng · Dana-Farber Cancer Inst · R01 · FY2022 · CA

Cancer Immunology Training Program

$518,655
Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · T32 · FY2023 · CA

Targeting Hippo pathway in melanoma

$518,652
Xu Wu · Massachusetts General Hospital · R01 · FY2023 · CA

Targeting Hippo pathway in melanoma

$518,652
Xu Wu · Massachusetts General Hospital · R01 · FY2022 · CA

Immune Regulation in the Microenvironment of Oropharyngeal Cancer

$518,635
Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2014 · CA

Localized immunotherapy using alum-binding therapeutics

$518,397
Darrell J Irvine · Massachusetts Institute Of Technology · R01 · FY2023 · EB

Molecular Determinants of Health Disparities in Inflammatory Breast Cancer

$518,284
Gayathri Devi · Duke University · R01 · FY2021 · CA

Deciphering the Molecular Mechanisms Underlying Cholangiocarcinoma Development

$518,219
Sungjin Ko · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA

Myct1 control of the angioimmune interface

$518,199
Kyunghee Choi · Washington University · R01 · FY2024 · CA

Advanced Sample Preparation, Separation and Multiplexed Analysis for In-Depth Proteome Profiling of >1000 Single Cells Per Day

$518,183
Ryan T Kelly · Brigham Young University · R01 · FY2024 · CA

Clonal Therapy for Pediatric T-cell Acute Lymphoblastic Leukemia

$518,050
Jiyang Yu · St. Jude Children'S Research Hospital · U01 · FY2023 · CA

Project 3: Dynamics of Immune Signatures and Microbiome in Patients with Cervical Pre-Cancer and Cancer Among Women.

$518,029
Vijayakumar Velu · University Of Miami School Of Medicine · U54 · FY2025 · CA

Tumor heterogeneity and early outcome prediction: efficacy, timing of MRI and PET

$517,986
Nina A. Mayr · University Of Washington · R01 · FY2013 · CA

Project 1: Strategies to enhance MEK inhibitor efficacy in MUTNRAS melanoma

$517,920
Roger S Lo · University Of California Los Angeles · P01 · FY2021 · CA